Glox Therapeutics awarded share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate
£500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosisProgramme delivered by CF AMR Syndicate offers cross-sector collaboration and support to address urgent un
Engineering biology to accelerate breakthroughs in human health
Sable&Hawkes have been appointed to work with DNA Script on a new set of customer-orientated messages and branded marketing and communications assets.
Metrion Biosciences listed in The Sunday Times 100 Tech, as one of Britain's fastest-growing private technology companies
Inaugural feature recognises companies within the UK technology sector, developing or selling a proprietary technology Listing is recognition of Metrion’s leadership position in preclinical ion channel drug discovery research servicesCambr
The Cambridge Young Professionals Group (CYPG) releases its memberships for 2025
The CYPG), a group for graduates and young professionals in the Cambridge area, has released its memberships for 2025.
CMR Surgical appoints Massimiliano Colella as Chief Executive Officer
Massimiliano Colella appointed CEO at CMR Surgical, leading the company in its mission to bring the benefits of robotic-assisted minimal access surgery to patients around the world with Versius
DNA damage can last unrepaired for years, changing our view of mutations
While most known types of DNA damage are fixed by our cells’ in-house repair mechanisms, some forms of DNA damage evade repair and can persist for many years, new research shows. This means that the damage has multiple chances to generate harmful mutations, which can lead to cancer.
Milner Therapeutics Institute announces 2025 Consortium Call
The 2025 Milner Therapeutics Consortium Call opened on 13 January, with an exciting new focus around pharma-led challenges.
Applications are now open for Accelerate@Babraham
Your opportunity to be part of one of the best Campus’ across the UK and Europe to start-up a life science venture.
Salus Wellness Clinics are excited to welcome Luminita Andreescu to the team
Luminita is a highly qualified acupuncturist with over 40 years of experience as a Registered Nurse and nearly 30 years as a Usui Reiki Master.
Owlstone Medical announces $27 Million USD first close in Series E financing round
Led by Ventura Capital and joined by other investors including Aviva Ventures, the Gates Foundation and Horizons Ventures Funding will be used to accelerate commercialization and further clinical trials of Breath Biopsy diagnostic tests and point of care devices fo
Evelyn Partners continues East of England professional services expansion with new Audit Director
Evelyn Partners continues East of England professional services expansion with new Audit Director.
We are excited to welcome One Day Tests to Salus Wellness this month.
One Day Tests provides a fast, convenient, and affordable option for managing your health through a wide range of private blood tests.
Bio-Rad launches Nuvia wPrime 2A media for biomolecule purification
Scalable Weak Anion Exchange and Hydrophobic Interaction (AEX-HIC) Mixed-Mode Chromatography Resin Enables Small- to Large-Scale Purification for Research and Biotherapeutic Applications
Sapio Sciences announces enhanced capabilities for chemistry, immunogenicity, GMP and molecular biology
Sapio Lab Informatics Platform (Release 24.12) further optimizes productivity across lab workflows
Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific Collaborate to Accelerate T Cell Expansion for Cell Therapy Developers
Turnkey solution helps simplify and scale T cell expansion using Fujifilm's PRIME-XV® T Cell Expansion Media on Terumo BCT’s Quantum Flex™ Cell Expansion System, easing the burden for developers
Enhanc3D Genomics launches suite of 3D multi-omics solutions to accelerate drug development
Solutions driven by proprietary, integrated multi-omics platform to support data-driven, faster and more precise drug discovery and development, to be introduced during JPM Week Provides customers with access to Enhanced’s 3D genomics technology and 3D Multi-Omic P
Pheno Therapeutics granted clinical trial authorisation for lead multiple sclerosis therapeutic candidate PTD802
UK MHRA grants CTA for first-in-human trial of a selective GPR17 antagonist Small molecule therapeutic designed for treatment of neurological diseases such as multiple sclerosisEdinburgh, UK, 14 January 2025: Pheno Therapeutics Li
CN Bio signs strategic partnership with Primetech Corporation to establish distribution channel for OOC solutions in Japan
Agreement establishes direct distribution channel for customers in Japan, providing local support and expertise Partnership solidifies CN Bio’s presence in Asian markets and supports ongoing global expansionCambridge, UK, 14 January 2025:
Sable&Hawkes appointed for major new environment design project with Gt Ormond Street Hospital
Great Ormond Street Hospital (GOSH) is a world-renowned international centre of excellence in child healthcare. Cambridge-based design and communication agency Sable&Hawkes was commissioned by GOSH to work with them on a major new environment and signage project.
Guardtech’s ‘full life cycle’ approach offering cleanroom facility protection from start to finish
Suffolk-based contamination control specialists’ holistic cleanroom installation programmes boast comprehensive maintenance and decontamination aftercare packages.
An open letter to the Government underscoring the critical role Greater Cambridge can play in the UK’s sustainable and inclusive national renewal
If science were a country then Cambridge would likely be its capital, and if discovery were a global competition the city and region would regularly be winning for Britain. That’s because Greater Cambridge is where innovation makes history and where the future comes first.
Human ‘Domainome’ reveals root cause of inherited conditions
The largest catalogue of human protein variants to date has revealed that protein destabilisation is the main driver of inherited genetic conditions and paves the way for precision medicine and AI-driven treatments.
4basebio appoints Gabe Longoria as Chief Commercial Officer
Cambridge, UK, 09 January 2025 - 4basebio PLC (AIM: 4BB) (“4basebio”), a company which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced the appointment of Gabe Long
Cambridge VR project wins international award
Cambridge lab wins Digital Health Award for cutting-edge virtual reality platform that eliminates the fear of public speaking.
Geneoscopy closes $105M in Series C funding round to power next-generation of gastrointestinal diagnostic tests
Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease